Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Death × Clear all

Phase

Phase NA 39 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 1123 Carcinoma, Non-Small-Cell Lung 713 Neoplasms 542 Prostatic Neoplasms 499 Colorectal Neoplasms 436 Multiple Myeloma 332 Lung Neoplasms 308 Neoplasm Metastasis 287 Leukemia, Myeloid, Acute 263 Stomach Neoplasms 248 Carcinoma, Hepatocellular 244 Ovarian Neoplasms 221 Rectal Neoplasms 210 Colonic Neoplasms 204 Lymphoma 199 Lymphoma, Follicular 198 Leukemia 190 Uterine Cervical Neoplasms 181 Head and Neck Neoplasms 174 Pancreatic Neoplasms 170 Lymphoma, Non-Hodgkin 166 Leukemia, Lymphocytic, Chronic, B-Cell 165 Lymphoma, Large B-Cell, Diffuse 163 Recurrence 160 Melanoma 157 Precursor Cell Lymphoblastic Leukemia-Lymphoma 153 Squamous Cell Carcinoma of Head and Neck 146 Pain 141 Urinary Bladder Neoplasms 138 Brain Neoplasms 133

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02319200 2017-01-11

METFOVIR

Assistance Publique - Hôpitaux de Paris

Phase 3 Terminated

Gastrointestinal

Death, Fibrosis, Carcinoma, Hepatocellular, Hepatitis C, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡